Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ambrisentan and Theophylline for Acute Mountain Sickness
NCT01902758Phase 3Completed
- Sponsor
- University of Montana
- Start
- Aug 2013
- Primary completion
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ambrisentan, theophylline in acute mountain sickness (AMS), sponsored by University of Montana. Started Aug 2013; status: completed.
02
Drugs
ambrisentantheophylline
03
Conditions
acute mountain sickness (AMS)
Beyond the preview
Go deeper on NCT01902758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01902758.